Skip Navigation


Rheumatology Advance Access originally published online on March 9, 2005
Rheumatology 2005 44(5):571-572; doi:10.1093/rheumatology/keh579
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
44/5/571    most recent
keh579v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hill, J.
Right arrow Articles by Hay, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, J.
Right arrow Articles by Hay, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

EDITORIAL

Meeting the challenges of research governance

J. Hill, N. Foster, R. Hughes and E. Hay

Keele University, Primary Care Sciences Research Centre, Stoke, Staffs, United Kingdom

Correspondence to: J. Hill. E-mail: j.hill@keele.ac.uk

The first 150 words of the full text of this article appear below.

There is a tangible sense of hostility being expressed among UK clinical researchers at present, directed at NHS Trusts’ implementation of the Department of Health's (DOH) Research Governance Framework (RGF) [1–4]. Researchers fear a decline in the UK's impressive research record due to the obstacles resulting from lengthy, complex, bureaucratic implementation procedures presented by research managers in NHS Trusts [5]. In addition, the UK health service has undergone radical organisational change, adding further complexities in the delivery of high quality research. Here we evaluate the impact of RGF particularly to multicentre clinical trials and contribute to the debate by sharing our personal experiences.

There is no doubt that patients must be assured that clinical research is undertaken to the highest standards, and an integral part of such an assurance includes improved standards of accountability. Urgent action has been required to address the crisis of public confidence . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?